Listen to the article
In a significant development within the healthcare sector, Atlanta-based Indian American urologist Jitesh Patel and his medical practice, Advanced Urology, have agreed to pay $14 million to settle allegations of fraudulent billing practices and performing unnecessary medical procedures.
The case emerged following whistleblower complaints filed by former employees of the practice. The first complaint alleged that Advanced Urology routinely performed medically unnecessary procedures on patients, while a second whistleblower later claimed that the practice systematically billed government healthcare programs for procedures and tests that were either never performed or lacked medical justification.
Federal investigators found evidence suggesting the practice’s business model was deliberately structured to maximize revenue for Patel and his associates at the expense of proper patient care. According to the U.S. Attorney’s Office for the Northern District of Georgia, which announced the settlement, the allegations represented serious violations of the False Claims Act.
“Physicians commit fraud when they seek payment for medically unnecessary procedures or bill for services they never performed,” said U.S. Attorney Theodore S. Hertzberg in a statement. “Our office will not tolerate abuse of patients or misuse of government funds, and we will enforce the False Claims Act to hold wrongdoers accountable.”
One of the central allegations involved a specific urological procedure known as Direct Visual Internal Urethrotomy (DVIU). This complex procedure involves using a specialized scope to dilate a patient’s urethra and a knife to cut tissue inside the urethra. The whistleblowers alleged that Advanced Urology routinely performed simpler urethral dilations but billed Medicare and Medicaid for the more complex and expensive DVIU procedure.
Such “upcoding” practices, where providers bill for more expensive procedures than those actually performed, represent a common form of healthcare fraud that costs taxpayers billions annually. The settlement highlights ongoing federal efforts to combat such practices in the $4.3 trillion U.S. healthcare industry.
Special Agent in Charge Kelly Blackmon of the U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG) emphasized the significance of the case, stating, “This action underscores our commitment to safeguarding federal health care programs from fraud and abuse.”
The whistleblowers who brought the case forward under the qui tam provisions of the False Claims Act will collectively receive $2.94 million from the settlement amount. The False Claims Act allows private citizens to file lawsuits on behalf of the government against those who defraud federal programs and to share in any recovery obtained.
The settlement comes amid increased scrutiny of medical billing practices across the country. In fiscal year 2023, the Department of Justice recovered over $2.7 billion from False Claims Act cases related to healthcare fraud, representing a significant portion of the government’s fraud recovery efforts.
For Advanced Urology, which operates multiple locations throughout the greater Atlanta area, the settlement represents a substantial financial blow. However, the agreement allows the practice to continue operations without admitting liability, while implementing enhanced compliance measures designed to prevent future violations.
Healthcare fraud experts note that cases like this one serve as important deterrents in the medical community. The combination of whistleblower incentives, substantial financial penalties, and potential reputational damage creates powerful incentives for healthcare providers to ensure their billing practices comply with federal regulations.
The case also highlights the critical role of healthcare workers in identifying and reporting suspected fraud within their organizations, as well as the effectiveness of whistleblower protection mechanisms in encouraging individuals to come forward with information about potential wrongdoing.
Fact Checker
Verify the accuracy of this article using The Disinformation Commission analysis and real-time sources.
10 Comments
This case is a sobering reminder that unethical billing practices can have serious consequences, even for prominent medical professionals. It’s important that healthcare providers prioritize patient care over profit motives.
Absolutely. Fraud in the medical industry erodes public trust and undermines the entire system. Whistleblowers play a vital role in exposing these abuses.
It’s disheartening to see an Indian American doctor engage in this kind of fraudulent behavior. This case underscores the need for greater oversight and accountability in the healthcare industry.
You’re right. This tarnishes the reputation of the medical profession, regardless of one’s background. Strict enforcement of regulations is crucial to upholding integrity in the system.
Performing unnecessary procedures and overbilling government programs is a betrayal of the medical oath. I hope this $14 million settlement serves as a strong deterrent against such egregious misconduct in the future.
Agreed. Patients deserve honest, ethical care, not a doctor’s attempt to maximize their own profits at the expense of proper treatment.
While I’m glad the authorities were able to uncover and address this fraud, it’s concerning that it went on for so long. We need stronger mechanisms to detect and prevent these abuses from happening in the first place.
You raise a good point. Proactive monitoring and auditing of billing practices could help identify issues earlier and deter providers from engaging in this kind of misconduct.
A $14 million settlement is a substantial penalty, but it’s important that justice is served. Patients who were subjected to unnecessary procedures deserve compensation and assurance that their care will improve going forward.
Absolutely. The whistleblowers who came forward should be commended for their courage in exposing this wrongdoing. Their actions have helped protect vulnerable patients.